Details:

Personal Author:
Grohskopf, Lisa A. ; Bresee, Joseph S. ; Cox, Nancy (Nancy J.) ; Shimabukuro, Tom T.
Grohskopf, Lisa A. ; Bresee, Joseph S. ; Cox, Nancy (Nancy J.) ; Shimabukuro, Tom T. Less -
Corporate Authors:
National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office. ; National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. ; United States. Advisory Committee on Immunization Practices.
National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office. ; National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. ; United States. Advisory Committee on Immunization Practices. Less -
Description:
In 2010, the Advisory Committee on Immunization Practices (ACIP) first recommended annual influenza vaccination for all persons aged ?6 months in the United States. Annual influenza vaccination of all persons aged ?6 months continues to be recommended. This document 1) describes influenza vaccine virus strains included in the U.S. seasonal influenza vaccine for 2012-13; 2) provides guidance for the use of influenza vaccines during the 2012-13 season, including an updated vaccination schedule for children aged 6 months through 8 years and a description of available vaccine products and indications; 3) discusses febrile seizures associated with administration of influenza and 13-valent pneumococcal conjugate (PCV-13) vaccines; 4) provides vaccination recommendations for persons with a history of egg allergy; and 5) discusses the development of quadrivalent influenza vaccines for use in future influenza seasons. Information regarding issues related to influenza vaccination that are not addressed in this update is available in CDC's Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 and associated updates.

Reported by Lisa Grohskopf, Timothy Uyeki, Joseph Bresee, Nancy Cox, Influenza Div, National Center for Immunization and Respiratory Diseases; Tom Shimabukuro, Immunization Safety Office, National Center for Zoonotic and Emerging Infectious Diseases, CDC.

6 p. (p. 613-618)


Content Notes:
none
Subjects:
[+]
Antigens, Viral/immunology Immunization Schedule Influenza, Human/epidemiology Influenza, Human/prevention & Control Influenza A Virus, H1N1 Subtype/immunology Influenza A Virus, H3N2 Subtype/immunology Influenza B Virus/immunology Influenza Vaccines/administration & Dosage Influenza Vaccines/adverse Effects Influenza Vaccines/immunology Influenza Vaccines/supply & Distribution Pneumococcal Vaccines/administration & Dosage Pneumococcal Vaccines/adverse Effects Practice Guideline Seasons Seizures, Febrile/etiology
Source:
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 61, no. RR-32, 613-618.
Pubmed ID:
22895385
Document Type:
Journal Article
Genre:
Guideline
Place as Subject:
United States
Collection(s):
Guidelines and Recommendations Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:
[+]
urn:sha256:229b55f0b240c693cabe283a53922f38be99b5325d523c7d39d2ecbefceca6bb
Download URL:
https://stacks.cdc.gov/view/cdc/20710/cdc_20710_DS1.pdf
File Type:

Supporting Files

• No Additional Files

More +